ically signiﬁcant disease, or such diseasedif present and
of a localized naturedcorrected by endovascular means
with conﬁrmed elimination of any translesional pressure gradients (<5 mm Hg mean pressure resting) before performing
the bypass.184 Interrogation and treatment of both donor
and recipient CFAs, as noted above, is imperative to optimize
long-term outcomes. The graft is placed in a deep subcutaneous, extrafasc